RE: Conference18 May 2020 20:20
Agreed, I spent ages reading all about this company, their website and watching the videos before investing
That said, I listed on them on my HL share tracker at 35p, so my timing is very poor on getting into this one. I let the spread get in the way of my instinct to buy, crazy but I'm in now. That said, recent new flow also did swing it for me as well, as it's so good. It was either this one or Open Orphan, which was 7.2p on my tracker....hindsight is wonderful
-------------------------------------------------
New York/London - May 11, 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for inflammatory and autoimmune diseases, announces that two abstracts on the Company's stem cell biology-based genomic tool, StemPrintER, for the prediction of disease recurrence in breast cancer patients, will be presented at the American Society of Clinical Oncology's 2020 Virtual Conference. All abstracts, including Abstract #1020, which compares Tiziana's product to current market leader Oncotype DX as part of a poster discussion session, will be available online beginning May 13, 2020 beginning at 5:00 PM ET at abstracts.asco.org. The American Society of Clinical Oncology (ASCO) Virtual Conference will be held from May 29-31, 2020.